PROFESSIONAL EDITION

The largest community of pharma leaders

Bio-Thera Solutions Announces Initiation of Phase I Clinical Trial for BAT1308, a Monoclonal Antibody Targeting PD-1

GUANGZHOU, China–(BUSINESS WIRE)– #PD1–Bio-Thera Solutions announced that dosing has begun in a Phase I clinical study of BAT1308, a monoclonal antibody targeting PD-1.
Source Read More

Recent Articles